Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





ISOPROPYL ALCOHOL								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 67-63-0; **Chemical Formula:** CH3CHOHCH3
The previous PEL for isopropyl alcohol was 400 ppm as an 8-hour TWA. OSHA proposed adding a 15-minute STEL of 500 ppm to this TWA, based on the ACGIH recommendation, and the final rule establishes these limits. In its posthearing comment, NIOSH (Ex. 150, Comments on Isopropyl Alcohol) endorsed OSHA’s proposal, stating that a STEL is necessary to reduce the risks of irritation and narcosis that can occur on short-term exposure to elevated concentrations of isopropyl alcohol. Isopropyl alcohol is a colorless, flammable liquid with a slight odor resembling that of rubbing alcohol.
Rats exposed at isopropyl alcohol concentrations of 12,000 ppm for four hours survived, but extending the duration of exposure to eight hours killed the animals (Smyth 1937-1955, as cited in ACGIH 1986/Ex. 1-3, p. 337).
Isopropyl alcohol has been demonstrated to be irritating to the eyes, nose, and throat in humans exposed for brief periods to 400 ppm (Nelson, Enge, Ross et al. 1943/Ex. 1-66); at 800 ppm, these symptoms were more intense. In addition, isopropyl alcohol has narcotic and irritative acute effects at higher concentrations. Weil and associates have reported that an excess of paranasal sinus cancers has been observed among workers manufacturing isopropyl alcohol (Weil, Smith, and Nale 1952/Ex. 1-453). However, it has been established that the cancers associated with isopropyl alcohol manufacture were caused by isopropyl oil and not by the isopropyl alcohol itself (NIOSH 1976g, as cited in ACGIH 1986/Ex. 1-3, p. 337).
No comments, other than NIOSH’s, were received on this substance. The irritant effects associated with exposure to isopropyl alcohol occur at concentrations only twice as high as the 8-hour TWA limit, even when the exposure lasts only for a brief period; exposures at this level clearly cause irritation, as documented by the study by Nelson et al. (1943/Ex. 1-66).
OSHA concludes that, in the absence of a STEL, workers are at significant risk of experiencing the narcotic and irritative effects associated with short-term exposures to isopropyl alcohol above the 8-hour TWA PEL of 400 ppm. Therefore, the Agency is retaining its 400 ppm 8-hour TWA limit for isopropyl alcohol and adding a 500 ppm 15-minute STEL to substantially reduce this significant risk. OSHA has determined that the narcosis and eye and mucous membrane irritation associated with chronic and acute exposures to isopropyl alcohol constitute material impairments of health and that a STEL is needed to protect workers from experiencing these harmful effects.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue